Tüdőrák: vizsgálatok itt: Franciaország
318 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisNot yet taking people in FranciaországSymbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
- Where
- Lyon, Marseille, Villejuif
- Életkor
- 18 év and over
- People
- 40 worldwide
- Run by
- Pfizer
See details and how to joinNCT07476287 · EU 2025-524686-24-00 - 3. fázisTaking peopleSymbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Where
- Angers, Besancon Cedex, Boulogne-Billancourt, Limoges Cedex 1, Nancy Cedex, Paris, Villejuif
- Életkor
- 18 év and over
- People
- 1410 worldwide
- Run by
- Pfizer
See details and how to joinNCT07222566 · EU 2025-523461-17-01 - 2/3. fázisNot yet taking people in FranciaországSymbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
- Where
- Boulogne-Billancourt, Villejuif
- Életkor
- 18 év and over
- People
- 550 worldwide
- Run by
- Pfizer
See details and how to joinNCT07226999 · EU 2025-523522-41-00 - 1/2. fázisTaking peopleSymbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
- Where
- Bordeaux, Dijon, Marseille, Paris
- Életkor
- 18 év and over
- People
- 162 worldwide
- Run by
- Pfizer
See details and how to joinNCT07227298 · EU 2025-523526-40-00 - 2. fázisNot yet taking people in FranciaországSymbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
- Where
- Bron, Lyon Cedex 04, Paris, Pierre-Bénite, Villejuif
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Pfizer
See details and how to joinNCT07489066 · EU 2025-524825-42-00 - No phaseTaking peopleBenchmarking Large Language Models Against Tumour Boards for Oncology Treatment Recommendations
- Where
- Boulogne-Billancourt, Paris
- Életkor
- 18 év and over
- People
- 100
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07739121 - 3. fázisTaking peopleA Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants with Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
- Where
- Angers, Bobigny Cedex, Caen Cedex 5, Lyon, Montpellier Cedex 5, Nice Cedex 2, Paris, Pessac, Pierre-Bénite, Reims Cedex, Saint-Quentin, Strasbourg Cedex, Vannes
- Életkor
- 18 év and over
- People
- 282 worldwide
- Run by
- F. Hoffmann-La Roche AG
See details and how to join2024-518365-10-00 - 2. fázisTaking peopleA Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
- Where
- Boulogne-Billancourt, Caen, Limoges, Lyon, Marseille, Paris, Pessac, Saint-Herblain, Strasbourg
- Életkor
- 18 év and over
- People
- 220 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT05967689 - No phaseTaking peopleProspective, Longitudinal Biocollection in Thoracic Oncology, Including Newly Diagnosed Lung Cancer Patients
- Where
- Angers, Nantes, Rennes, Tours
- Életkor
- 18 év and over
- People
- 730
- Run by
- Nantes University Hospital
See details and how to joinNCT06481813 - 1. fázisTaking peoplePhase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
- Where
- Paris, Saint-Herblain, Villejuif
- Életkor
- 18 év and over
- People
- 180 worldwide
- Run by
- Olema Pharmaceuticals, Inc.
See details and how to joinNCT06784193 - 2/3. fázisTaking peopleA Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- Where
- Brest, Grenoble Cedex 9, Lille, Marseille, Montpellier, Paris, Saint-Herblain Cedex, Villejuif
- Életkor
- 18 év and over
- People
- 490 worldwide
- Run by
- AbbVie
See details and how to joinNCT07155187 · EU 2025-521124-29-00 - 1/2. fázisTaking peopleThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Where
- Bordeaux, Clermont-Ferrand, Lyon, Nîmes, Saint-Herblain, Strasbourg, Toulouse, Vandœuvre-lès-Nancy, Villejuif
- Életkor
- 12 év and over
- People
- 300 worldwide
- Run by
- PMV Pharmaceuticals, Inc
See details and how to joinNCT04585750 - 3. fázisTaking peopleEffect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer
- Where
- Angers, Clermont-Ferrand, Dijon, La Rochelle, Lille, Mulhouse, Nancy Cedex, Nice Cedex 2, Nimes Cedex 9, Paris Cedex 18, Reims, Saint-Grégoire, Saint-Quentin, Villefranche Sur Saone Cedex
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Pharmacosmos A/S
See details and how to joinNCT07473128 · EU 2025-525026-35-00 - 1. fázisTaking peopleStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Besancon Cedex, Bordeaux, Caen Cedex 5, Clermont Ferrand Cedex1, Marseille, Nice Cedex 2, Paris, Rennes Cedex, Saint-Herblain, Strasbourg Cedex 2, Vandoeuvre Les Nancy_ Cedex, Villejuif
- Életkor
- 18 év and over
- People
- 1394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00 - No phaseTaking peopleIntegrating Artificial Intelligence Into Lung Cancer Screening.
- Where
- Nice
- Életkor
- 18 év to 80 év
- People
- 2722
- Run by
- Centre Hospitalier Universitaire de Nice
See details and how to joinNCT05704920 - 1/2. fázisTaking peopleA Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
- Where
- Grenoble Cedex 9, Lille, Lyon, Marseille, Paris, Paris Cedex 20, Pessac, Rennes, Saint-Herblain, Suresnes, Tours, Villejuif
- Életkor
- 18 év and over
- People
- 123 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06362252 · EU 2023-509629-36-00 - 1. fázisTaking peopleOpen-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Where
- Bordeaux, Lyon, Montpellier, Saint-Cloud, Saint-Herblain, Villejuif
- Életkor
- 18 év and over
- People
- 392 worldwide
- Run by
- TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
See details and how to joinNCT06625775 · EU 2024-519445-29-00 - 2. fázisTaking peopleA Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)
- Where
- Angers, Avignon Cedex 9, Bordeaux, Dijon, Marseille, Paris, Saint-Herblain Cedex
- Életkor
- 18 év and over
- People
- 243 worldwide
- Run by
- Shanghai Henlius Biotech
See details and how to joinNCT06907615 · EU 2025-523803-31-00 - 3. fázisTaking peopleNeladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
- Where
- Angers, Bordeaux, Caen Cedex 5, Lyon, Marseille, Montpellier, Paris, Pessac, Saint-Herblain, Toulouse, Villejuif
- Életkor
- 18 év and over
- People
- 450 worldwide
- Run by
- Nuvalent Inc.
See details and how to joinNCT06765109 · EU 2024-517553-26-00 - 3. fázisTaking peopleA Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
- Where
- Avignon Cedex 9, Bordeaux, Boulogne-Billancourt, Caen Cedex 5, Chambéry, Dijon, Grenoble Cedex 9, Limoges, Paris, Pau, Saint-Herblain, Saint-Herblain Cedex, Saint-Malo Cedex, Toulouse Cedex 3, Tours
- Életkor
- 18 év and over
- People
- 830 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06868277 · EU 2024-517780-24-00 - 2. fázisTaking peopleImmunotherapy Without Chemotherapy for Advanced Lung Cancer Patients With High PD-L1 Levels
- Where
- Boulogne-Billancourt, Créteil, Nice Cedex 2, Toulon Cedex, Villejuif
- Életkor
- 18 év and over
- People
- 275
- Run by
- UNICANCER
See details and how to joinNCT07360743 · EU 2025-522655-26-00 - 1/2. fázisTaking peopleA Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
- Where
- Lyon, Nantes, TOULOUSE, Villejuif
- Életkor
- 12 év and over
- People
- 359 worldwide
- Run by
- Nuvalent Inc.
See details and how to joinNCT05118789 · EU 2024-511793-71-00 - 1/2. fázisTaking peopleA Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
- Where
- Bordeaux, Caen, Lyon, Marseille, Montpellier, Nice, Paris, Villejuif
- Életkor
- 18 év and over
- People
- 416 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06618287 - 3. fázisTaking peopleA Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Where
- Créteil, Grenoble Cedex 9, Marseille, Nice Cedex 2, Paris, Rennes, Saint-Herblain
- Életkor
- 18 év and over
- People
- 531 worldwide
- Run by
- AbbVie
See details and how to joinNCT07365241 · EU 2025-523819-11-00 - 1. fázisTaking peopleA study of Daraxonrasib (RMC-6236) in combination with pembrolizumab in participants with nonsmall cell lung cancer with certain mutations -Subprotocol B
- Where
- Bordeaux, Bron, Caen Cedex 5, Dijon, Lille, Paris, Saint-Herblain, Suresnes, Toulouse Cedex 9, Villejuif
- Életkor
- 18 év and over
- People
- 180 worldwide
- Run by
- Revolution Medicines Inc.
See details and how to join2023-509572-42-00